Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer

Cancer Chemotherapy and Pharmacology

Volumn 70, Issue 6, 2012, Pages 899-902

  Lucchetta, Marta ^a   Lonardi, Sara ^b   Bergamo, Francesca ^b   Alberti, Paola ^c   Velasco, Roser ^d   Argyriou, Andreas A ^e   Briani, Chiara ^a   Bruna, Jordi ^d   Cazzaniga, Marina ^f   Cortinovis, Diego ^f   Cavaletti, Guido ^c   Kalofonos, Haralabos P ^e  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e UNIVERSITY OF PATRAS   (Greece)

^f SAN GERARDO HOSPITAL   (Italy)

Author keywords

Acute neurotoxicity; Atypical Presentation; Hyperexcitability; Oxaliplatin; Uncommon symptoms

Indexed keywords

CAPECITABINE; FLUOROURACIL; OXALIPLATIN;

ACUTE NERVE HYPEREXCITABILITY SYNDROME; ADULT; AGE; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DYSESTHESIA; DYSPHAGIA; DYSPHONIA; DYSPNEA; FASCICULATION; FEMALE; HUMAN; INCIDENCE; JAW SPASM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MUSCLE CRAMP; MUSCLE SPASM; NEUROTOXICITY; PARESTHESIA; PATIENT MONITORING; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOLARYNGOSPASM; PTOSIS; SYNDROME; VISUAL DISORDER;

ACUTE DISEASE; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DEGLUTITION DISORDERS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; DYSPNEA; FEMALE; FLUOROURACIL; HUMANS; INCIDENCE; LEUCOVORIN; MALE; MIDDLE AGED; NEUROTOXICITY SYNDROMES; ORGANOPLATINUM COMPOUNDS; PARESTHESIA; PROSPECTIVE STUDIES; SPASM;

EID: 84871257426     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-012-2006-8     Document Type: Article

References (9)

1. Argyriou AA, Polychronopoulos P, Iconomou G et al (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev 34(4):368-377
2. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G (2012) Chemotherapy- induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82(1):51-77
3. Park SB, Lin CS, Krishnan AV et al (2011) Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy. Exp Neurol 227(1):120-127
4. Santini D, Vincenzi B, La Cesa A et al (2003) Recurrent episodes of involuntary masticatory spasms induced by continuous infusion of oxaliplatin. J Natl Cancer Inst 95(20):1555-1556
5. Park SB, Goldstein D, Lin CS et al (2009) Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 27(8):1243-1249
6. Park SB, Lin CS, Krishnan AV et al (2009) Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain 132(10):2712-2723
7. Bongenhielm U, Nosrat CA, Nosrat I et al (2000) Expression of sodium channel SNS/PN3 and ankyrin(G) mRNAs in the trigeminal ganglion after inferior alveolar nerve injury in the rat. Exp Neurol 164(2):384-395
8. Grolleau F, Gamelin L, Boisdron-Celle M et al (2001) A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 85(5):2293-2297
9. Petrioli R, Pascucci A, Francini E et al (2008) Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin. Cancer Chemother Pharmacol 61(1):105-111